These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 2989413)

  • 41. Recombinant Epstein-Barr virus with small RNA (EBER) genes deleted transforms lymphocytes and replicates in vitro.
    Swaminathan S; Tomkinson B; Kieff E
    Proc Natl Acad Sci U S A; 1991 Feb; 88(4):1546-50. PubMed ID: 1847527
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Induction of latent membrane protein expression in in vitro Epstein-Barr virus-infected leukaemic B lymphocytes by interleukin 4 and antibodies to CD40.
    Crawford DH; Thomas JA; Gregory CD; Catovsky D; Chaggar K
    Leukemia; 1995 May; 9(5):747-53. PubMed ID: 7539512
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Epstein-Barr virus (EBV) induces expression of B-cell activation markers on in vitro infection of EBV-negative B-lymphoma cells.
    Calender A; Billaud M; Aubry JP; Banchereau J; Vuillaume M; Lenoir GM
    Proc Natl Acad Sci U S A; 1987 Nov; 84(22):8060-4. PubMed ID: 2825176
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Human B cells on their route to latent infection--early but transient expression of lytic genes of Epstein-Barr virus.
    Kalla M; Hammerschmidt W
    Eur J Cell Biol; 2012 Jan; 91(1):65-9. PubMed ID: 21450364
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A third viral nuclear protein in lymphoblasts immortalized by Epstein-Barr virus.
    Hennessy K; Fennewald S; Kieff E
    Proc Natl Acad Sci U S A; 1985 Sep; 82(17):5944-8. PubMed ID: 2994055
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cytotoxic T-cell clones discriminate between A- and B-type Epstein-Barr virus transformants.
    Moss DJ; Misko IS; Burrows SR; Burman K; McCarthy R; Sculley TB
    Nature; 1988 Feb; 331(6158):719-21. PubMed ID: 2830541
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immortalization of human lymphocytes by Epstein-Barr virus.
    Miller G
    Yale J Biol Med; 1982; 55(3-4):305-10. PubMed ID: 6295007
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterization of an antigen whose cell surface expression is induced by infection with Epstein-Barr virus.
    Sugden B; Metzenberg S
    J Virol; 1983 Jun; 46(3):800-7. PubMed ID: 6304342
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Activation of lymphocytes from Epstein-Barr virus-seronegative donors by autologous Epstein-Barr virus-transformed cells.
    Chang RS; Chang YY
    J Infect Dis; 1980 Aug; 142(2):156-62. PubMed ID: 6251138
    [TBL] [Abstract][Full Text] [Related]  

  • 50. EBV infection of mitogen-stimulated human B lymphocytes.
    Einhorn L; Klein E
    Int J Cancer; 1981 Feb; 27(2):181-3. PubMed ID: 6270012
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Epstein-Barr virus (EBV) receptors, complement receptors, and EBV infectibility of different lymphocyte fractions of human peripheral blood. II. Epstein-Barr virus studies.
    Einhorn L; Steinitz M; Yefenof E; Ernberg I; Bakacs T; Klein G
    Cell Immunol; 1978 Jan; 35(1):43-58. PubMed ID: 202404
    [No Abstract]   [Full Text] [Related]  

  • 52. Induction of EBNA precedes the first cellular S-phase after EBV-infection of human lymphocytes.
    Einhorn L; Ernberg I
    Int J Cancer; 1978 Feb; 21(2):157-60. PubMed ID: 203544
    [TBL] [Abstract][Full Text] [Related]  

  • 53. EBV-activation of human B-lymphocytes.
    Aman P; Lewin N; Nordström M; Klein G
    Curr Top Microbiol Immunol; 1986; 132():266-71. PubMed ID: 3024919
    [No Abstract]   [Full Text] [Related]  

  • 54. The activation antigen BLAST-2, when shed, is an autocrine BCGF for normal and transformed B cells.
    Swendeman S; Thorley-Lawson DA
    EMBO J; 1987 Jun; 6(6):1637-42. PubMed ID: 3038527
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Transformation of lymphocytes by Epstein-Barr virus requires only one-fourth of the viral genome.
    Mark W; Sugden B
    Virology; 1982 Oct; 122(2):431-43. PubMed ID: 6293180
    [No Abstract]   [Full Text] [Related]  

  • 56. Calcium concentration defines two stages in transformation of lymphocytes by Epstein-Barr virus.
    Moss DJ; Burrows SR; Parsons PG
    Int J Cancer; 1984 May; 33(5):587-90. PubMed ID: 6327539
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vitro infection of human B lymphocytes with adult T-cell leukemia virus.
    Okada M; Koyanagi Y; Kobayashi N; Tanaka Y; Nakai M; Sano K; Takeuchi K; Hinuma Y; Hatanaka M; Yamamoto N
    Cancer Lett; 1984 Feb; 22(1):11-21. PubMed ID: 6321019
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Epstein-Barr virus transformation of human pre-B cells.
    Hansson M; Falk K; Ernberg I
    J Exp Med; 1983 Aug; 158(2):616-22. PubMed ID: 6310019
    [TBL] [Abstract][Full Text] [Related]  

  • 59. EBV utilizes a unique activation pathway for the transformation of human B cells.
    Dosch HM; Lam P; Hui MF; Hibi T; Cheung RK
    Int Immunol; 1990; 2(9):833-48. PubMed ID: 2177646
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Infection of human B lymphocytes with high multiplicities of Epstein-Barr virus: kinetics of EBNA expression, cellular DNA synthesis, and mitosis.
    Robinson J; Smith D
    Virology; 1981 Mar; 109(2):336-43. PubMed ID: 6259815
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.